INSTINCT BIO TECHNICAL CO HOLDINGS INC. (BIOT) Form 6-K — Oct 16, 2026
Instinct Bio (Nasdaq: BIOT) reported its first results since its July 2026 Nasdaq listing: 1H FY2026 revenue rose 4.7% to USD 1.14 million (up 9.8% in yen terms) and the group swung to a profit after tax of USD 90,251 from a loss of USD 206,817 a year earlier. The improvement came largely from non-recurrence of about USD 208,000 in listing fees, while gross margin fell 7.1 points to 72.6% on smaller inventory builds, new imported purchases and higher manufacturing overhead.
Key figures
- Eps
- 0
- Revenue
- 1142598
- Net Income
- 90251
- Total Debt
- lease liabilities of USD 172,453; no bank borrowings
- Revenue Yoy
- 4.7% USD / 9.8% JPY terms
- Total Assets
- 4080414
- Cash Position
- 25565
- Gross margin
- 72.6% (vs 79.7% prior period)
- Total equity
- 2086187
- Total liabilities
- 1994227
- Deacq equity consideration
- US$225 million business combination with Relativity Acquisition Corp (23 July 2026)
- Top customer revenue share
- 34.8% (from 51.7%)
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.